Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The World Anti-Doping Agency (WADA) prohibits AOD-9604 as a non-approved substance and potential performance-enhancing agent in athletics, citing concerns about unfair advantage through lean body mass gains (if efficacious, which remains unproven)
We do, however, accept flex spending or health savings cards
B vitamins may also be useful
Catalog Preview Online Ordering Coming Soon The cart is temporarily disabled while BGX Performance prepares secure payment processing
Mounjaro (tirzepatide) is a prescription medication licensed by the MHRA for the treatment of type 2 diabetes mellitus and for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
